At the same time, its current use is guided more by emerging knowledge than by definitive evidence
Similar agents such as iopanoic acid (10) and diatrizoate meglumine have been used at the doses described
Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: a randomized, controlled, proof-of-concept trial
43 , W154W159 (2015)
All participants were healthy, free-living volunteers with a mean age of 34 years and a male to female ratio of 29:51
Side effects are generally mild and temporary: slight bruising at the injection site, temporary flushing, or a metallic taste in the mouth (common with Vitamin C or NAD+)